WESAIL Biotech is committed to supporting IVD diagnostic partners with excellent performance reagents and analyzers, including colloidal gold and immunofluorescence platforms. Based on deep insights into the future POCT industry development trends, WESAIL continuously launches reagents and analyzers in various disease areas, including cardiovascular, metabolism, fertility, inflammation, diabetes, hormone, brain injury, renal injury, thyroid, tumor marker, etc. At the end of 2019, WESAIL urgently develops COVID-19 testing reagents. In 2020, a colloidal gold test kit for detecting COVID-19 was launched. WESAIL's main hot-selling products are as follows: -COVID-19 Antigen Test Kit (Incubation Period) -COVID-19 IgM/IgG Antibody Test Kit (Early & Acute Infections) -Flu+COVID-19 Antigen Test Kit (Incubation Period & Early Infections) -COVID-19 Neutralizing Antibody Test Kit (Vaccine Effectiveness Evaluation) E-mail: sales@wesailbio.com